Target Name: ZNF430
NCBI ID: G80264
Review Report on ZNF430 Target / Biomarker Content of Review Report on ZNF430 Target / Biomarker
ZNF430
Other Name(s): Zinc finger protein 430 (isoform 1) | FLJ13659 | ZNF430 variant 1 | ZN430_HUMAN | zinc finger protein 430 | Zinc finger protein 430, transcript variant 1 | Zinc finger protein 430

ZNF430: A Potential Drug Target and Biomarker

Zinc finger proteins (ZFPs) are a family of non-coding RNAs that play a crucial role in various cellular processes. ZNF430 is a ZFP that is expressed in various tissues and has been identified as a potential drug target and biomarker. In this article, we will explore the biology of ZNF430 and its potential as a drug target.

Biogenesis and Expression

ZNF430 is a 21 kDa protein that is expressed in various tissues, including brain, heart, and pancreas. It is highly conserved across different species, which suggests that it has a critical role in evolution. ZNF430 is predominantly expressed in the brain and has been shown to be involved in various cellular processes, including cell adhesion, migration, and survival.

Function and Interaction

ZNF430 is involved in several signaling pathways, including the TGF-灏? pathway and the Wnt pathway. TGF-灏? is a well-known signaling pathway that regulates cell growth, differentiation, and survival, and it is involved in the development and maintenance of tissues. The TGF-灏? pathway is also involved in the regulation of cell-cell adhesion, which is critical for tissue formation and maintenance.

Wnt is another signaling pathway that is involved in cell-cell adhesion and has been implicated in various diseases, including cancer. ZNF430 has been shown to be involved in the regulation of Wnt signaling in various tissues, including the regulation of stem cell self-renewal and the regulation of neural stem cell proliferation.

Drug Target Potential

ZNF430 has been identified as a potential drug target due to its involvement in several cellular processes that are associated with various diseases, including cancer. ZNF430 has been shown to be involved in the regulation of cell adhesion, which is critical for the development and maintenance of tissues. It is also involved in the regulation of stem cell self-renewal and the regulation of neural stem cell proliferation, which are critical for the development and maintenance of neural tissues.

In addition, ZNF430 has been shown to be involved in the regulation of various signaling pathways, including the TGF-灏? pathway and the Wnt pathway. These signaling pathways are involved in the regulation of various cellular processes, including cell growth, differentiation, and survival, which are critical for the development and maintenance of tissues.

Biomarker Potential

ZNF430 has also been identified as a potential biomarker for several diseases, including cancer. ZNF430 has been shown to be involved in the regulation of cell adhesion, which is critical for the development and maintenance of tissues. It is also involved in the regulation of stem cell self-renewal and the regulation of neural stem cell proliferation, which are critical for the development and maintenance of neural tissues.

Conclusion

ZNF430 is a ZFP that is involved in several cellular processes that are critical for the development and maintenance of tissues. Its potential as a drug target and biomarker makes it an attractive target for researchers to explore. Further studies are needed to fully understand the biology of ZNF430 and its potential as a drug target and biomarker.

Protein Name: Zinc Finger Protein 430

Functions: May be involved in transcriptional regulation

The "ZNF430 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF430 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF431 | ZNF432 | ZNF433 | ZNF433-AS1 | ZNF436 | ZNF436-AS1 | ZNF438 | ZNF439 | ZNF44 | ZNF440 | ZNF441 | ZNF442 | ZNF443 | ZNF444 | ZNF445 | ZNF446 | ZNF449 | ZNF45 | ZNF451 | ZNF454 | ZNF460 | ZNF461 | ZNF462 | ZNF467 | ZNF468 | ZNF469 | ZNF470 | ZNF471 | ZNF473 | ZNF473CR | ZNF479 | ZNF48 | ZNF480 | ZNF483 | ZNF484 | ZNF485 | ZNF486 | ZNF487 | ZNF488 | ZNF490 | ZNF491 | ZNF492 | ZNF493 | ZNF496 | ZNF497 | ZNF497-AS1 | ZNF500 | ZNF501 | ZNF502 | ZNF503 | ZNF503-AS1 | ZNF503-AS2 | ZNF506 | ZNF507 | ZNF510 | ZNF511 | ZNF512 | ZNF512B | ZNF513 | ZNF514 | ZNF516 | ZNF516-DT | ZNF517 | ZNF518A | ZNF518B | ZNF519 | ZNF519P3 | ZNF521 | ZNF524 | ZNF525 | ZNF526 | ZNF527 | ZNF528 | ZNF528-AS1 | ZNF529 | ZNF529-AS1 | ZNF530 | ZNF532 | ZNF534 | ZNF536 | ZNF540 | ZNF541 | ZNF542P | ZNF543 | ZNF544 | ZNF546 | ZNF547 | ZNF548 | ZNF549 | ZNF550 | ZNF551 | ZNF552 | ZNF554 | ZNF555 | ZNF556 | ZNF557 | ZNF558 | ZNF559 | ZNF559-ZNF177 | ZNF560